Search

Atopic dermatitis is a chronic cutaneous inflammatory disease, intensely pruritic, presenting frequent relapses, all these characteristics making it difficult to treat. The disease has an important impact on the patients' quality of life. Due to chronic evolution, the treatment requires a long-term perspective. More than 10% of the population has atopic dermatitis, most of them at a very young age. As time passes, the symptoms may disappear or, in some cases, it can take a chronic course, with periods of exacerbation. The complete etiopathology of the atopic dermatitis is yet unknown, the etiology being multifactorial. Recent studies have shown the importance of the genetic components. The most common factors related to atopic dermatitis are: the socio-economic status, the number of family members, polution, soaps and detergents. Moreover, there is a strong correlation between the impairment of the skin barrier functions, the environmental factors and the genetics ones. The diagnosis is based on the presence of some well established major and minor criteria, but the key symptom is the chronic pruritus. The main differential diagnoses that should be taken into consideration are: seborrheic dermatitis, nummular eczema, irritant contact dermatitis.The therapeutic strategies are based on the severity of the disease, a large number of treatment options being available nowadays, topic (wet dressings, occlusive dressings, topical steroids, calcineurin inhibitors) and systemic (cyclosporin, steroids, azathioprine, intravenous immunoglobulin, histaminoglobin vaccine). The moisturizers play an essential role in the treatment strategy, alleviating the pruritus, preventing the relapses and allowing a lower dose of topical steroids to be used. In some cases, phototherapy can be associated. If left untreated, the lesions may persist for an indefinite period of time, but in some cases there are spontaneous remissions, especially during childhood. Some patients may develop asthma or any other type of allergy. Moreover, atopic dermatitis increases the risk of infection of the lesions, which can extend and complicate, sometimes threatening the patients' life. [ABSTRACT FROM AUTHOR]

Copyright of Medic.ro is the property of MEDICHUB MEDIA, S.R.L. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Infectio.ro is the property of MEDICHUB MEDIA, S.R.L. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Hidradenitis suppurativa is a chronic inflammatory skin disease, with a poor therapeutic response and a significant impact on the patient's quality of life. The aim of this review-type article is to assess the role of bacterial infections in both the pathogenesis and evolution of the hidradenitis suppurativa, but also to evaluate the convenience of antibiotherapy in the management of the disease. Antibiotherapy plays an important role in its longterm management, mainly due to the anti-inflammatory action of the frequently recommended agents from the schemes of treatment. The therapy's initiation ought to be consistent with the antibiotic sensitivity profile of microorganisms isolated in the laboratory, personalized depending on the disease’s severity, history of antibiotic use, the risk of drug interactions and the patient's comorbidities. Moreover, the association of antibiotics with anti-TNF-α (tumour necrosis factor) biologic therapy represents a valid therapeutic alternative that can significantly enhance the quality of life, of great utility especially in severe disease stages. In order to elucidate the pathogenesis, we propose two main research directions. Firstly, the profile analysis of virulence of microorganisms and its correlation with the host response to bacterial insult. Secondly, the description of the bacterial biofilm communities, both architecturally and physiologically in-depth analyzes of inter-cellular communication mechanisms. These steps are necessary for the discovery of new therapeutic agents. [ABSTRACT FROM AUTHOR]